🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Haemonetics Corporation

HAE Healthcare
$90.57 +$0.19 (0.21%)
Market Cap: $4.12 B
Gurus Holding
7
Popularity Rank
#1266
% of Shares Held
12.69%
Net Activity (Q2 2026)
+$160.49 M

Guru Ownership Trend

Guru Analysis for Haemonetics Corporation (HAE)

Haemonetics Corporation (HAE), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $522.87 M.

Top institutional holders include Cliff Asness and John Rogers.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $160.49 M net inflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 200.9%. Conversely, Steven Cohen reduced exposure by 93.3%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$161.08 M
Total Buy Value
New Buys 1
Additions 1
-$591,780
Total Sell Value
Reductions 0
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for Haemonetics Corporation (HAE)

Major holders include Cliff Asness ($185.68 M), John Rogers ($154.57 M), Renaissance Technologies (RenTech) ($9.75 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 5.77 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $160.49 M, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited HAE. The total reported sell value was $591,780.

Yes, 1 managers opened new positions in HAE, and 1 increased their existing holdings. The total reported buy value was $161.08 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.09% Add 6.1% 3,356,543 $185.68 M Q1 2026
1.54% New Buy 2,060,966 $154.57 M Q2 2026
0.01% Add 200.9% 130,000 $9.75 M Q2 2026
0.04% 71,475 $5.36 M Q2 2026
0.00% Reduce -93.3% 56,868 $3.21 M Q1 2026
0.01% Add 159.6% 48,842 $2.75 M Q1 2026
0.01% New Buy 48,377 $2.73 M Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form